Jove
Visualize
Contact Us

Related Experiment Videos

Quality management program and misadministrations--Nuclear Regulatory Commission. Final rule

    Federal Register
    |July 2, 1991
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same journal

    Findings of Research Misconduct.

    Federal register·2026
    Same journal

    Findings of Research Misconduct.

    Federal register·2026
    Same journal

    Findings of Research Misconduct.

    Federal register·2026
    Same journal

    Findings of Research Misconduct.

    Federal register·2025
    Same journal

    Findings of Research Misconduct.

    Federal register·2025
    Same journal

    Findings of Research Misconduct.

    Federal register·2024
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies

    The Nuclear Regulatory Commission (NRC) is updating rules for radioactive materials in therapy. New quality management programs will ensure patient safety and accurate treatment delivery by physicians.

    Area of Science:

    • Nuclear Medicine
    • Radiological Safety
    • Medical Physics

    Background:

    • Current regulations govern therapeutic uses of byproduct material and radioactive sodium iodide.
    • Existing frameworks may not sufficiently ensure precise administration of radioactive materials in medical treatments.
    • The need for enhanced patient safety and adherence to physician directives in radiation therapy is recognized.

    Purpose of the Study:

    • To amend regulations requiring quality management programs for therapeutic administrations of byproduct material.
    • To ensure byproduct material or radiation is administered as directed by an authorized user physician.
    • To enhance patient safety in a cost-effective manner while maintaining medical judgment flexibility.

    Main Methods:

    • Amending existing regulations set forth by the Nuclear Regulatory Commission (NRC).

    Related Experiment Videos

  • Implementing a performance-based approach to quality management in therapeutic nuclear medicine.
  • Modifying notification, reporting, and recordkeeping requirements for quality management and misadministrations.

    • Main Results:

    • Introduction of mandatory quality management programs for specific radioactive material uses.
    • Establishment of a framework for high confidence in correct administration of radioactive materials.
    • Streamlined administrative processes concerning program oversight and incident reporting.

    Conclusions:

    • The regulatory amendment is expected to enhance patient safety in therapeutic nuclear medicine.
    • The new quality management program requirements are designed to be cost-effective.
    • The changes allow for necessary flexibility, minimizing interference with clinical decision-making by physicians.